Cymevene 500 mg powder for concentrate for solution for infusion

Licence status
Authorised: 17/08/2018
Active substances
Ganciclovir
Dosage Form
Powder for concentrate for solution for infusion
Licence number
PA2239/003/001
Licence holder
CHEPLAPHARM Arzneimittel GmbH

Product documents

Licence information

ATC code
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors, J05AB06 ganciclovir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/08/2018